NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/15/2020
Back to search
Official data from USPTO
BLUEPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
09/15/2020
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
11/02/2009
Registration date
02/15/2011
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/15/2020
Last transaction
09/15/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
03
Owner location
3040-086 Coimbra, PT
Examiner
SOUDERS, MICHAEL
Law office
M60
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the term "bluepharma" in blue below a light blue wavelike design.
Holders and representatives
Holders
Bluepharma - Industria Farmaceutica, S.A.
Representatives
David A. Weinstein
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of gastrointestinal acid related disorderscardiovascular system diseasesinflammatory diseases and rheumatic disordersalimentary tract and metabolism disordersthrombotic disorderscholesterolbone diseasesgenito-urinary system diseasesfungal infectionsnervous system disordersallergic reactions
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/15/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/15/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/15/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
08/05/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/15/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/03/2017
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/03/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/03/2017
ES8R
TEAS SECTION 8 RECEIVED
11/21/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2011
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
01/07/2011
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
09/23/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/24/2010
PUBO
PUBLISHED FOR OPPOSITION
08/24/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/22/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2010
ALIE
ASSIGNED TO LIE
07/17/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/05/2010
GNRT
NON-FINAL ACTION E-MAILED
02/05/2010
CNRT
NON-FINAL ACTION WRITTEN
02/05/2010
DOCK
ASSIGNED TO EXAMINER
02/05/2010
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
11/06/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2009
NWAP
NEW APPLICATION ENTERED
11/05/2009
Continuous trademark protection
Get notified about every new filing that threatens BLUEPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.